Thursday March 24, 2022 1:00-2:00pm Eastern
Circulating cell-free DNA (cfDNA)-based testing
is rapidly becoming an integral part of oncology care. Technical advances
are allowing detection of a range of genomic alterations for diagnosis,
prognosis, treatment selection and disease monitoring to support unique patient
care needs at different stages of the care cycle. An evidence-based framework
is important in evaluating tumor type and biomarker specific evidence for
clinical applications. This presentation will include discussion on existing
and emerging clinical and technical applications of cfDNA tumor tests.
1. Evaluate existing evidence for clinical liquid biopsy applications in oncology.
2. Discuss emerging applications of ctDNA testing in oncology practices.
3. Develop strategies to evaluate different genomic alterations using cfDNA.
 |
 |
|---|---|
| Speaker: Keyur Patel, MD, PhD |
Moderator: Marjorie Parker David, MD, MS |
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account by clicking here.
- Complete the "Demographic questionnaire for the "Utility of Cell-Free DNA in the Clinic Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: April 24, 2022
Physicians (ACCME)
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association for Molecular Pathology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live to enduring activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM (1.00 CE for each webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical Laboratory Education (CMLE)
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for up to 8 CMLE credits. ASCP CMLE credits are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation
